Chris Jacobs bought Axsome Therapeutics Inc (NASDAQ: AXSM)
Chris Jacobs (R-NY), a U.S. Representative, has disclosed 1 trade in Axsome Therapeutics Inc (AXSM) since 2022, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Chris Jacobs bought $15,001 - $50,000 of Axsome Therapeutics Inc (NASDAQ: AXSM) on June 16, 2022. Since that trade, AXSM is up +946.09% against the S&P 500 up +110.25%, an outperformance of +835.84%.
Data updated
Chris Jacobs's AXSM trades vs the price
AXSM is up +946.09% since Chris Jacobs bought on June 16, 2022, versus +110.25% for the S&P 500.
Performance since this trade
All Chris Jacobs AXSM trades
Chris Jacobs & AXSM trading FAQ
Is it legal for Chris Jacobs to trade Axsome Therapeutics Inc (AXSM) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Axsome Therapeutics Inc (AXSM), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Chris Jacobs buy AXSM?
Chris Jacobs disclosed a purchase of $15,001 - $50,000 of Axsome Therapeutics Inc (AXSM) on June 16, 2022, according to public STOCK Act filings.
How has AXSM performed since Chris Jacobs's trade?
Since Chris Jacobs bought AXSM on June 16, 2022, the stock is up +946.09%, versus +110.25% for the S&P 500 over the same period, an outperformance of +835.84%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional AXSM trades?
Quantellect tracks every disclosed congressional trade in Axsome Therapeutics Inc (AXSM) on the Axsome Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
Chris Jacobs's AXSM tradesAll congressional filings for Axsome Therapeutics IncChris Jacobs's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.